Bernard Mignotte
email: mignotte@genetique.uvsq.fr

Jean-Luc Vayssiere

MITOCHONDRIAL CONTROL OF APOPTOSIS

Keywords: m, mitochondrial membrane potential, PCD, programmed cell death, PT, permeability transition, ROS, reactive oxygen species, DEVD, acetyl-Asp-Glu-Val-Asp-aldehyde, TNF-, tumor necrosis factor-, SOD, superoxide dismutase, NGF, nerve growth factor, AIF, apoptosis inducing factor, Apaf-1, apoptosis protease-activating factor 1, ANT, adenine nucleotides translocase, GSH, glutathione Programmed cell death / apoptosis / caspase / mitochondria / Bcl-2

Programmed cell death (PCD) serves as a major mechanism for the precise regulation of cell numbers, and as a defense mechanism to remove unwanted and potentially dangerous cells. Despite the striking heterogeneity of cell death induction pathways, the execution of the death program is often associated with characteristic morphological and biochemical changes termed apoptosis. In both worm and mammalian cells, the antiapoptotic members of the Bcl-2 family act upstream of the "execution caspases" somehow preventing their proteolytic processing into active killers.

Two main pathways connect Bcl-2 family proteins to caspases. In the first one, antiapoptotic Bcl-2 family proteins maintain cell survival by dragging execution caspases to intracellular membranes (probably the mitochondrial membrane) and by preventing their activation. The mammalian protein Apaf-1, the mammalian equivalent of CED-4, could be the physical link between Bcl-2 family proteins and caspases. In the second one, Bcl-2 would act by regulating the release from mitochondria of caspases activators: cytochrome c and/or AIF (Apoptosis-Inducing-Factor). This crucial position of mitochondria in PCD control is reinforced by the observation that mitochondria contribute to PCD signaling via the production of reactive oxygen species, as shown in TNF--or ceramide-induced cell death during which increased mitochondrial ROS production appears as an early event of the induction phase. In this chapter, we examine the data concerning the mitochondrial features of PCD.

INTRODUCTION

The programmed cell death cascade can be conveniently divided into several phases. During the activation phase, multiple signaling pathways lead from the various death-triggering signals to the central control of the cell death machinery and activate it. This is followed by the execution stage, in which the activated machinery acts on multiple cellular targets, and, finally, the destruction phase in which the dead or dying cell is broken down.

A most important clue to the molecular nature of the death program came initially from genetic studies in C. elegans that led to the identification of a dozen cell death genes (ced) that are responsible for one aspect or another of cell death processes [START_REF] Ellis | Mechanisms and functions of cell death[END_REF]. Three of these genes stand out. Two, ced-3 and ced-4 are essential for cell death. The third, ced-9, antagonizes the death activities of ced-3 and ced-4.

Mutational analyses of these genes had been placed ced-4 between ced-9 and ced-3 in the pathway leading to cell death, suggesting that CED-4 might act as an adaptator, linking the upstream regulator CED-9 to the downstream death effector CED-3 [START_REF] Shaham | Developing Caenorhabditis elegans neurons may contain both cell-death protective and killer activities[END_REF]. Biochemical approaches have provided insight into the mechanism by which programmed cell death is regulated in the nematode. CED-4 interacts directly and simultaneously with both CED-3 and CED-9 forming a multimeric protein complex (Chinnaiyan et al., 1997b;Wu et al., 1997a). Furthermore, oligomerized CED-4, acting as a context dependent ATPase, promotes CED-3's activation and its ability to induced apoptosis (Chinnaiyan et al., 1997a).

CED-9 binding to CED-4, mutually exclusive with CED-4 oligomerization, prevents it from activating CED-3, thereby blocking cell death [START_REF] Yang | Essential role of CED-4 oligomerization in CED-3 activation and apoptosis [see comments[END_REF]. Remarkably, all three of these C. Elegans cell death genes have mammalian counterparts that are likely to play similar, albeit more complex, roles in mammalian cell death (Table 1). CED-3 protein turned out to be a member of a family of cystein proteases, known as caspases (cystein aspartases). The mammalian caspase family now comprises at least ten known members, most of which have been definitively implicated in PCD (for review see [START_REF] Cryns | Proteases to die for[END_REF]). All cleave their substrates after specific aspartic acids and are themselves activated by cleavage at specific aspartic acids [START_REF] Nicholson | Caspases: killer proteases[END_REF]. Caspases mediate PCD by cleaving selected intracellular proteins, including proteins of the nucleus, nuclear lamina, cytoskeleton, endoplasmic reticulum, and cytosol. However, which of these targets is, if any, responsible for the cell blebbing, condensation and fragmentation that characterize PCD remains uncertain. As specific protein or peptide caspase inhibitors can block PCD in all animal and invertebrate cells and in most cell death inducing conditions, it seems likely that caspases form the core of the death program.

Recent studies have identified and partially characterized Apaf-1 (Apoptotic protease-activating factor-1), a mammalian homologue of C. elegans CED-4 [START_REF] Zou | Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3[END_REF]. The N-terminal region of Apaf-1 shares amino acid homology with CED-4 and several caspases with long prodomains, including, caspase-4. -8. -9, and CED-3. This conserved region, that has been termed caspase recruitment domain (CARD), mediates the physical association of CARD-containing proteins [START_REF] Hofmann | The CARD domain: a new apoptotic signalling motif[END_REF]. Thus, Ced-4 binding to Ced-3 involves their respective amino-terminal protein interaction modules. In a such way, Apaf-1 was shown to interact with caspase-9, a mammalian caspase containing a N-terminal long prodomain, and to trigger caspase-9 proteolytic self-activation (Li et al., 1997b). Caspase-9 subsequently proteolyses and activates caspase-3, one of the execution caspases which kill the cell by cleaving key intracellular death targets.

Bcl-2 family proteins act at least in part at the mitochondrial level CED-9 protein is homologous to a family of many members termed the Bcl-2 family in reference to the first discovered mammalian cell death regulator (for review see [START_REF] Adams | The Bcl-2 protein family: arbiters of cell survival[END_REF]). Some members, such as Bcl-2 or Bcl-xL, are negative regulators of cell death, able to prevent cells from undergoing apoptosis induced by various stimuli in a wide variety of cell types [START_REF] Korsmeyer | Bcl-2 initiates a new category of oncogenes: regulators of cell death[END_REF][START_REF] Zhong | bcl-2 inhibits death of central neural cells induced by multiple agents[END_REF], whereas others, such as Bax, Bid and Egl-1 promote or accelerate cell death. All members possess at least one of four conserved motifs known as Bcl-2 homology domain (BH1 to BH4).

Most pro-survival members contain at least BH1 and BH2, and those most similar to Bcl-2 have all four BH domains. Two pro-apoptotic subfamilies can be define according to their relatedness to Bcl-2. Bax, Bak and Bok, which contain BH1, BH2 and BH3, resemble Bcl-2 fairly closely. In contrast, the other known mammalian and nematode EGL-1 "killers" possess only the central BH3 domain. These "BH3 domain" proteins may represent the physiological antagonists of the pro-survival proteins, because programmed cell death in C. elegans requires Egl-1, which binds to and acts via CED-9.

BH3 is essential for the function of the "killers", including Egl-1.

The various family members (referred to here as Bcl-2s) can heterodimerize and seemingly titrate one another's function, suggesting that their relative concentration may act as a rheostat for the suicide program.

Heterodimerization is not required for pro-survival function. For pro-apoptotic activity, heterodimerization is essential in the BH3 domain group, but less so for those of the Bax group, which may have an independent cytotoxic impact.

Indeed whether Bax binds to Bcl-2 inside cells has become controversial. Some death agonists may preferentially target subsets of the death repressors.

Bok, for example, interacts with Mcl-1 and the Epstein-barr viral protein BHFR1 but not with Bcl-2 or Bcl-xL. Within the BH3 group, Bid is promiscuous, binding to Bax and Bak as well as to the anti-apoptotic proteins, but the others bind only to certain of the death inhibitors.

However, the mechanism(s) by which proteins of the Bcl-2 family modulate apoptosis remains elusive and several conflicting theories have been proposed. A widely accepted model postulates that homodimers of Bax promote apoptosis, and that the functional effect of Bcl-2 related proteins is to form competing heterodimers with Bax that cannot promote apoptosis [START_REF] Oltvai | bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death[END_REF][START_REF] Sedlak | Multiple Bcl-2 family members demonstrate selective dimerizations with Bax[END_REF]. However, in some systems, Bax binding by Bcl-2 was not sufficient to prevent apoptosis and the overexpression of Bcl-2 or Bcl-xL can repress apoptosis in the absence of Bax [START_REF] Cheng | Bax-independent inhibition of apoptosis by Bcl-x L[END_REF][START_REF] Knudson | Bcl-2 and Bax function independently to regulate cell death[END_REF]. Thus, while an in vivo competition exists between Bax and Bcl-2, each is able to regulate apoptosis independently.

CED-9, Bcl-2 [START_REF] Akao | Multiple subcellular localization of Bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes[END_REF][START_REF] Chen | The bcl-2 candidate protooncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation[END_REF][START_REF] De Jong | Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells[END_REF][START_REF] Hockenbery | Bcl-2 is an inner mitochondrial protein that blocks programmed cell death[END_REF][START_REF] Janiak | Assembly of Bcl-2 into microsomal and outer mitochondrial membranes[END_REF][START_REF] Krajewski | Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes[END_REF][START_REF] Nakai | The bcl-2 protein is inserted into the outer membrane but not into the inner membrane of rat liver mitochondria in vitro[END_REF][START_REF] Nguyen | Targeting of bcl-2 to the mitochondrial outer membrane by a COOH-Terminal signal anchor sequence[END_REF], Bcl-x L [START_REF] Gonzalez-Garcia | bcl-X L is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria[END_REF],

Mcl-1 [START_REF] Wang | Antiapoptotic action of 1,25dihydroxyvitamin D3 is associated with increased iitochondrial MCL-1 and RAF-1 proteins and reduced release of cytochrome c[END_REF][START_REF] Yang | The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2[END_REF], the BHRF1 Epstein-Barr virus protein [START_REF] Hickish | Ultrastructural localization of BHRF1: an Epstein-Barr virus gene product which has homology with bcl-2[END_REF] and probably other members of the Bcl-2 family are localized to the cytoplasmic surfaces of the nuclear envelope, the endoplasmic reticulum and the outer mitochondrial membrane. However, it must be underlined that only a fraction of Bcl-x L resides on membranes, and that Bax seems to be cytosolic before an apoptotic stimulus, even though both, like most other family members, bear a C-terminal membrane anchor. The membrane association of Bcl-2 is of functional significance as mutant Bcl-2 molecules lacking this membrane anchorage capacity are less effective at preventing apoptosis in some systems [START_REF] Borner | The protein bcl-2 alpha does not require membrane attachment, but two conserved domains to suppress apoptosis[END_REF][START_REF] Nguyen | Role of membrane anchor domain of Bcl-2 in suppression of apoptosis caused by E1B-defective adenovirus[END_REF][START_REF] Zhu | Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types[END_REF]. Indeed, it has been reported that, in inhibiting apoptosis of MDCK cells, a mutant Bcl-2 molecule whose anchorage is targeted specifically to the mitochondria is as effective as the wild type protein, whereas mutant Bcl-2 targeted to the ER loses this capacity [START_REF] Zhu | Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types[END_REF]. In contrast, Bcl-2 targeted to the ER in the Rat-1/myc fibroblasts proved to be more active than when targeted to mitochondria. Thus, Bcl-2 mutants with restricted subcellular location reveal distinct pathways for apoptosis depending on cell type. When associated to the endoplasmic reticulum membrane, Bcl-2 could be involved in maintenance of the calcium homeostasis [START_REF] Distelhorst | Bcl-2 inhibits hydrogen peroxide-induced ER Ca2+ pool depletion[END_REF][START_REF] He | Maintenance of Calcium Homeostasis in the Endoplasmic Reticulum by Bcl-2[END_REF][START_REF] Lam | Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes[END_REF], while it could modulate protein subcellular trafficking through nuclear pores [START_REF] Ryan | c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle[END_REF].

Recent reports provide spectacular advancements in the understanding of the mechanism of action of antiapoptotic Bcl-2s. It was shown that, in both worm and mammalian cells, the antiapoptotic Bcl-2s act upstream of the "execution caspases" somehow preventing their proteolytic processing into active killers [START_REF] Golstein | Controlling Cell Death[END_REF][START_REF] Shaham | Developing Caenorhabditis elegans neurons may contain both cell-death protective and killer activities[END_REF]. How these proteins perform this feat remains unknown although two main mechanisms of action have been proposed to connect Bcl-2s to caspases.

In the first one, pro-survival proteins would act by regulating the release of some caspases activators usually sequestered in intracellular compartments. Apoptosis (in vivo and in vitro) involved the preliminary shift to the cytosol of regulatory components, namely cytochrome c or AIF (Apoptosis-Inducing-Factor), previously sequestered in mitochondrial intermembrane space (Kluck et al., 1997a;[START_REF] Susin | Bcl-2 inhibits the mitochondrial release of an apoptogenic protease[END_REF][START_REF] Yang | Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked[END_REF]. Cytosolic cytochrome c forms an essential part of the vertebrate "apoptosome" which is composed of cytochrome c, Apaf-1 and procaspase-9 (Li et al., 1997b). The result is the activation of caspase-9, which then activates other caspases to orchestrate execution of cell death. AIF (Apoptosisinducing factor) is another caspase-activating protein which promotes nuclear apoptosis in vitro probably via the activation of procaspase-3, a major executive caspase. Overexpression of Bcl-2/Bcl-xL in cells or addition of recombinant Bcl-2 to cell-free systems containing mitochondria prevented cytochrome c/AIF's exodus from the mitochondria that was trigerred normally by a wide variety of apoptogenic stimuli. In contrast, the pro-apoptotic member Bax stimulates mitochondrial cytochrome c release. The ability of Bax, Bcl-2/Bcl-xL to form membranes pores with distinct ion-conducting properties may provide a clue to how Bcl-2s can regulate the permeability of the intracellular membranes [START_REF] Reed | Double identity for proteins of the Bcl-2 family[END_REF]).

An alternative model proposes that the pro-survival proteins may function downstream the release of apoptogenic factors, by directly inhibiting the ability of CED-4 like proteins to activate caspases. This model arose from the elucidation of the role of the somewhat mysterious CED-4 protein [START_REF] Hengartner | Apoptosis. CED-4 is a stranger no more[END_REF]. Indeed, it was first shown that CED-9 interacts with CED-3 via the bridging protein CED-4 that binds simultaneously to CED-9 and CED-3. CED-9 prevents CED-4 from inducing proteolytic processing and activation of CED-3 (Chinnaiyan et al., 1997b;Wu et al., 1997b). These observations, concerning developmental cell death in C. elegans, were extended to mammalian PCD (Chinnaiyan et al., 1997b). An equivalent ternary complex was found to be present in mammalian cells involving Apaf-1, caspase-9 and Bcl-xL, in which Bcl-xL inhibits Apaf-1-mediated maturation of caspase-9. In this paradigm, pro-apoptotic relatives like Bik may free CED-4/Apaf-1 from the death inhibitor. Furthermore, there is some evidence that binding of pro-survival proteins to the apoptosome complex alter its location in cells, pulling it from the cytosol to the intracellular membranes where Bcl-2s often reside (Chinnaiyan et al., 1997b;Wu et al., 1997b).

Thus, the mitochondrion seems to constitute a pivot component of all the mechanisms of activation either as docking sites, via Bcl-2 family proteins, of caspases or as sequestering organelles of caspase activators. This crucial position of mitochondria in PCD control may be reinforced by the results obtained from distinct approaches establishing that mitochondria can contribute to PCD via the production of cell death signaling ROS. This chapter examines the data concerning the mitochondrial features of PCD and the way by which Bcl-2 family proteins participates in the modulation of these mitochondrial events (recent reviews on similar subjects: [START_REF] Mignotte | Mitochondria and apoptosis[END_REF][START_REF] Zamzami | Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins[END_REF]).

PERMEABILITY TRANSITION MARKS A POINT OF NO-RETURN OF CELLS CONDEMNED TO DIE

A decrease in mitochondrial membrane potential precedes DNA fragmentation during apoptosis Several changes in mitochondrial biogenesis and function are associated with the commitment to apoptosis. A fall of the membrane potential (m) occurs before the fragmentation of the DNA in oligonucleosomal fragments [START_REF] Kroemer | The biochemistry of programmed cell death[END_REF][START_REF] Petit | Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocytes apoptosis[END_REF][START_REF] Vayssière | Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with Simian Virus 40[END_REF]Zamzami et al., 1995a;Zamzami et al., 1995b). This drop of m is responsible for a defect of maturation of mitochondrial proteins synthesized in the cytoplasm [START_REF] Mignotte | SV40 induced cellular immortalization : phenotypic changes associated with the loss of proliferative capacity in a conditionally immortalized cell line[END_REF], cessation of mitochondrial translation and an uncoupling of the oxidative phosphorylations [START_REF] Vayssière | Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with Simian Virus 40[END_REF].

The drop of m is detectable whatever the apoptosis induction signal, physiological (absence of growth factor, glucocorticoids, TNF) or nonphysiological (irradiation, chemotherapy). These data showed on the one hand that the nuclear fragmentation is a late event as compared to the drop of the m and, on the other hand, that this drop marks the point of no-return of a cell condemned to die.

Mitochondrial permeability transition provokes a m decrease

What is the mechanism involved in the m disruption? The permeability transition (PT) is a phenomenon that is characterized by the opening of large conductance channels known as the mitochondrial PT pores and by its sensitivity to very low concentration of cyclosporine A. These pores, permeable to compounds of molecular mass up to 1500 Da are formed under specific conditions. The opening of these PT pores in the inner membrane allows for an equilibration of ions within the matrix and intermembrane space of mitochondria, thus dissipating the H+ gradient across the inner membrane and uncoupling the respiratory chain. These events lead to the decrease of the m and the arrest of ATP synthesis [START_REF] Bernardi | Modulation of the mitochondrial permeability transition pore. Effect of protons and divalent cations[END_REF][START_REF] Petronilli | Regulation of the permeability transition pore, a voltage-dependent mitochondrial channel inhibited by cyclosporin A[END_REF]. Perhaps more importantly, PT pore opening results in a volume dysregulation of mitochondria due to the hyperosmolarity of the matrix, which cause the matrix space to expand. Because the inner membrane a larger surface area than the outer membrane, this matrix volume expansion can eventually provokes outer membrane rupture, releasing intermembrane space molecules into the cytosol. Furthermore, permeability transition has properties of self-amplification: the drop of the m that is linked to depletion of non-oxidized glutathione [START_REF] Macho | Glutathione depletion is an early and calcium elevation is a late event of thymocyte apoptosis[END_REF], and that result from the opening of the PT pores would increase the permeability transition in a retrograde manner. We have therefore proposed that the opening of the PT pore may constitute an irreversible state of apoptosis and could account for the apparent synchronization in the drop of m that takes place simultaneously in all the mitochondria of a same cell [START_REF] Kroemer | The biochemistry of programmed cell death[END_REF]. The molecular composition of these PT pores remains elusive. The peripheral benzodiazepin receptor, that has recently been implicated in the protection against ROS [START_REF] Carayon | Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage[END_REF], and the translocase of adenine nucleotides (ANT) are probable components of the PT pore. Indeed, protoporphyrine IX and PK11195, that are ligands of the benzodiazepin receptor, induce a drop of m and consequently apoptosis [START_REF] Hirsch | PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses bcl-2-mediated cytoprotection[END_REF]Zamzami et al., 1996a).

On the contrary, N-methyl Val-4-cyclosporin A (a derivative of cyclosporine that is not immunosuppressor) and bongkrekic acid that bind to the matrix side of the ANT, prevent the drop of the mitochondrial potential. Altogether, these results sustain the hypothesis that the opening of PT pores is involved in the disruption of m observed during apoptosis.

Direct interventions on the mitochondrial permeability transition modulate apoptosis

Direct alterations of mitochondria can induce apoptosis [START_REF] Halliwell | Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease[END_REF][START_REF] Wolvetang | Mitochondrial respiratory chain inhibitors induce apoptosis[END_REF]. The links between mitochondrial perturbations and nuclear alterations have been studied by means of acellular systems where purified nuclei and purified mitochondria are confronted [START_REF] Newmeyer | Cell-free apoptosis in Xenopus egg extracts: inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria[END_REF]. Such a system allows to study reciprocal and direct effects of one organelle on another and to characterize at the biochemical level the factors involved.

These experiments have shown that when mitochondria are treated with substances capable to induce PT pores opening, they provoke nuclear apoptosis (condensation of the chromatin and fragmentation of the DNA) (Zamzami et al., 1996b). A correlation between induction of the PT and nuclear apoptosis has been observed by using a variety of known inductors of the PT such as atractyloside, pro-oxidants, calcium, protonophores and substances that provoke linkage of thiol groups such as diamide. These substances, that have no direct effect on nuclei in absence of mitochondria, confer pro-apoptotic properties upon mitochondria. The pro-apoptotic character (induction of nuclear apoptosis) of the mitochondria treated with atractyloside is altered by inhibitors of the PT such as bongkrekic acid, cyclosporine A and substances like monochlorobimane that block the crosslinking of the thiols. Cyclosporine A can be replaced by its nonimmunosuppressor analogue, N-methyl Val-4-cyclosporine A, which shows that its inhibitory effect on PT and nuclear apoptosis is independent from its calcineurine activity. These results suggest the implication of the PT pores opening in the regulation of apoptosis induced via the mitochondria.

Nuclei and mitochondria have been purified from hybridomas of T cells transfected by bcl-2 to study how Bcl-2 suppress apoptosis in in vitro experiments (Zamzami et al., 1996b). Upon treatment with atractyloside, in contrast to mitochondria purified from control cells, mitochondria purified from cells transfected by bcl-2 do not provoke nuclear apoptosis. On the contrary, nuclei purified from cells transfected by bcl-2 show a condensation of the chromatin and a fragmentation of the DNA when they are confronted to control mitochondria treated with atractyloside. Furthermore, bcl-2 inhibits the induction of permeability transition by agents such as atractyloside, oxidants and protonophores. These results show that, even if Bcl-2 intervenes also during latter apoptotic events [START_REF] Guénal | Bcl-2 and Hsp27 act at different levels to suppress programmed cell death[END_REF][START_REF] Marton | Apoptotic cell death induced by inhibitors of energy conservation--Bcl-2 inhibits apoptosis downstream of a fall of ATP level[END_REF] and on m loss induced by other mechanisms [START_REF] Shimizu | Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux[END_REF], at least a part of its activity is exerted by acting on the mitochondrial permeability transition [START_REF] Decaudin | Bcl-2 and Bcl-X L antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents[END_REF]. Moreover, the structure of a protein of the Bcl-2 family (Bcl-xL) has been established [START_REF] Muchmore | X-ray and NMR structure of human Bcl-X L , an inhibitor of programmed cell death[END_REF]. It recalls that of bacterial toxins, especially the diphtheria toxin, that form a pH-sensitive transmembrane channel. Furthermore, the pro-apoptotic Bax protein can form channels [START_REF] Antonsson | Inhibition of Bax Channel-Forming Activity by Bcl-2[END_REF], as reported also for the anti-apoptotic proteins Bcl-xL [START_REF] Minn | Bcl-x L forms an ion channel in synthetic lipid membranes[END_REF] and Bcl-2 [START_REF] Schendel | Channel formation by antiapoptotic protein Bcl-2[END_REF].

However, the intrinsic properties of Bax and those of Bcl-xL and Bcl-2 reveal differences. The channel forming activity of Bcl-xL and Bcl-2 is observed at highly acidic pH while Bax form channel in a wide range of pH including at pH=7, those found in cells. Furthermore, Bcl-2 can block the pore-forming activity of Bax. Indeed, recent results suggest that Bax might produces cell death by inducing PT [START_REF] Pastorino | The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition[END_REF]. Bcl-2 might counteract this effect of Bax on mitochondrial membranes [START_REF] Gross | Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis[END_REF].

MITOCHONDRIA OF CELLS UNDERGOING APOPTOSIS RELEASE PRO-APOPTOTIC FACTORS

Mitochondria undergoing permeability transition liberate AIF factor.

. The experiments described above showed that mitochondria from apoptotic cells can effectively control nuclear apoptosis and suggest the involvement of mitochondria derived products in the apoptotic cascade.

Acellular experiments have permitted to show that mitochondria contain a preformed approximately 50-kD protein which is released upon PT pores opening and which causes isolated nuclei to undergo apoptotic changes such as chromatin condensation and internucleosomal DNA fragmentation (Fig. 1).

This apoptosis-inducing factor (AIF) derived from the mitochondria is a protease (or a protease-activating protein) which is blocked by the general caspase inhibitor Z-VAD and is capable to activate purified procaspase-3 [START_REF] Susin | Bcl-2 inhibits the mitochondrial release of an apoptogenic protease[END_REF]. As expected, when preventing mitochondrial permeability transition, Bcl-2 overexpressed in the outer mitochondrial membrane also impedes the release of AIF from isolated mitochondria. In contrast, Bcl-2 does not affect the formation of AIF, which is contained in comparable quantities in control mitochondria and in mitochondria from Bcl-2-hyperexpressing cells.

Furthermore, the presence of Bcl-2 in the nuclear membrane does not interfere with the action of AIF on the nucleus, nor does Bcl-2 overexpression protect cells against AIF. It thus appears that Bcl-2 prevents apoptosis by favoring the retention of an apoptogenic protein in mitochondria [START_REF] Susin | Bcl-2 inhibits the mitochondrial release of an apoptogenic protease[END_REF].

Cytochrome c is released by mitochondria during apoptosis

Another mitochondrial killer component has been demonstrated

through the role of cytochrome c in PCD. Indeed, translocation of cytochrome c from mitochondria to cytosol has been shown to be a crucial step in the activation of the PCD machinery in various death models, including Fas-, UV-, staurosporine or etoposide-treated mammalian cells, in a cell-free system using Xenopus egg extracts or dATP-primed cytosols of growing cells (Kluck et al., 1997a;[START_REF] Krippner | Loss of Function of Cytochrome c in Jurkat Cells Undergoing Fas-mediated Apoptosis[END_REF][START_REF] Liu | Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c[END_REF][START_REF] Yang | Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked[END_REF].

Furthermore, direct microinjection of cytochrome c into the cytosol can induce apoptosis in various cell types (Li et al., 1997a;[START_REF] Zhivotovsky | Injected cytochrome c induces apoptosis[END_REF].

Cytochrome c is an essential component of the mitochondrial respiratory chain: it accepts an electron from cytochrome c reductase and passes it on to cytochrome c oxidase. It is a soluble protein that is located in the intermembrane space and is loosely attached to the surface of the inner mitochondrial membrane. Cytochrome c is translated on cytoplasmic ribosomes as apocytochrome c and follows a unique pathway into mitochondria that does not require the signal sequence, electrochemical potential and general protein translocation machinery [START_REF] Mayer | Translocation of Apocytochrome c accross the Outer membrane of Mitochondria[END_REF].

The apoprotein, on entry into the intermembrane space, gains an heme group, to become the fully folded holocytochrome c. This globular, positively charged protein can no longer pass through the outer mitochondrial membrane and is thought to become electrostatically attached to the inner membrane.

Upon its release into the cytoplasm during the initiation of apoptosis, cytochrome c promotes the assembly of a multiprotein complex, the apoptosome, that induces proteolytic processing and activation of executive caspases (Li et al., 1997b). Biochemical studies have shown that, besides cytochrome c, caspase-9, Apaf-1 and (d)ATP constituted the activating components of this complex. Apaf-1 and caspase-9 interact via their CARD domains, an association that requires dATP and cytochrome c. Binding of dATP and cytochrome c to Apaf-1 likely alters it's conformation and renders its CARD domain more available to caspase-9. Once bound to caspase-9,

Apaf-1 triggers caspase-9 proteolytic self-activation; caspase-9 subsequently proteolyses and activates caspase-3.

Many data suggested that the pro-survival Bcl-2 proteins prevent cell death acting upstream the release of cytochrome c. Overexpresssion of Bcl-2 or Bcl-xL in cells blocks the release of cytochrome c and aborts the apoptotic response triggered by a wide variety of killing signals [START_REF] Bossy-Wetzel | Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization[END_REF][START_REF] Kharbanda | Role for bcl-X L as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis[END_REF][START_REF] Van Der Heiden | Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria[END_REF][START_REF] Yang | Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked[END_REF].

On the contrary, caspases inhibitors have no effect on this process. Similarly, addition of recombinant Bcl-2 to Xenopus egg extracts containing mitochondria slows down the release of cytochrome c from these mitochondria and inhibits nuclear apoptosis observed in this cell-free system (Kluck et al., 1997a). Moreover, co-immunoprecipitation studies have shown that Bcl-xL can bind cytochrome c and may thereby act to sequester it in the mitochondria [START_REF] Kharbanda | Role for bcl-X L as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis[END_REF]. Bcl-xS , a pro-apoptotic derivative of Bcl-xL, was found to prevent the formation of the Bcl-xL-cytochrome c complex. In contrast, overexpression of the pro-apoptotic Bcl-2 family member Bax in cells stimulates both the release of cytochrome c and apoptosis. By using isolated mitochondria and recombinant Bax, it was shown that Bax can directly induce cytochrome c release from mitochondria.

Similarly, recent reports show that Bid, a BH3 domain-containing proapoptotic Bcl-2 family member, induces cytochrome c release and apoptosis after its caspase-8-dependent cleavage and subsequent translocation onto mitochondria [START_REF] Li | Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade[END_REF][START_REF] Luo | Bid, a Bcl-2 Interacting Protein, Mediates Cytochrome c release from Mitochondria in Response to Activation of Cell surface Death receptors[END_REF]. Even though, altogether, these results provide evidence that Bcl-2 family members can modulate cell death process by directly controlling the availability of cytochrome c in the cytosol (Fig. 1), it must underlined that pro-survival actors, as Bcl-2/ Bcl-xL, may also act downstream of cytochrome c to prevent caspase activation under certain circumstances (see below) [START_REF] Rosse | Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c[END_REF][START_REF] Zhivotovsky | Injected cytochrome c induces apoptosis[END_REF].

Although efflux of cytochrome c from mitochondria appears to be a crucial step in the killing cascade initiated by a wide range of apoptogenic stimuli, it must be underlined that this event is not an universal requirement for death signal transduction. Indeed, on the one hand, apoptosis can occur in the absence of detectable cytochrome c release [START_REF] Chauhan | Cytochrome c-dependent and -independent induction of apoptosis in multiple myeloma cells[END_REF][START_REF] Tang | Apoptosis in the absence of cytochrome c accumulation in the cytosol [In Process Citation[END_REF] and, on the other hand, under certain circumstances, cytochrome c release is not sufficient to promote cell death (Li et al., 1997a). Moreover, it was reported that efflux of cytochrome c could constitutes only a later event of the cell death, in other words, a side effect of the terminal dismantelment of the cell [START_REF] Adachi | Lack of Release of Cytochrome c from Mitochondria into Cytosol Early in the Course of Fasmediated Apoptosis of Jurkat Cells[END_REF][START_REF] Krippner | Loss of Function of Cytochrome c in Jurkat Cells Undergoing Fas-mediated Apoptosis[END_REF]. However, in this Fasmediated apoptosis model, an inactivation of cytochrome c, correlated to the inhibition of mitochondrial respiration at the cytochrome c level, constitutes an very early causal event in the apoptotic program. It was suggested that inactivation of cytochrome c is associated to its release from the outer surface of the inner mitochondrial membrane where normally it functions as a shuttle connecting respiratory chain energy transducers [START_REF] Skulachev | Cytochrome c in the apoptotic and antioxidant cascades[END_REF]. More intriguing, the authors suggest that efflux of cytochrome c which had been associated with early events of apoptosis could be, in some instances, the result of a methodological artifact [START_REF] Adachi | Lack of Release of Cytochrome c from Mitochondria into Cytosol Early in the Course of Fasmediated Apoptosis of Jurkat Cells[END_REF]. Indeed, most studies are based on subcellular fractionations, i.e.: after cell disruption, centrifugation allows to separate soluble cytosolic elements in the supernatant from heavy membranes, including mitochondria, included in the pellet. In this approach, the in vivo cytochrome c redistribution is inferred from its appearance into the cytosolic fraction during the in vitro procedure. In fact, this method could be more properly considered as a measure of cytochrome c extractability from mitochondria rather than as a exact view of its in situ localization. For instance, some minor alterations of the outer mitochondrial membrane c could be compatible with a mitochondrial localization of cytochrome c in the cell and its outflow from mitochondria as fractionation provoked breakdown of the fragilized outer membrane. However, these considerations refute neither the early occurrence of cytochrome c release in various apoptotic models as observed by in situ immunolocalization and nor its crucial role in the apoptotic program, ascertained by direct microinjection of cytochrome c in the cytosol.

They must be correlated to the evidenced existence of alternative pathways, i.e. cytochrome c independent, in the transduction of apoptogenic stimuli [START_REF] Chauhan | Cytochrome c-dependent and -independent induction of apoptosis in multiple myeloma cells[END_REF]Li et al., 1997a;[START_REF] Tang | Apoptosis in the absence of cytochrome c accumulation in the cytosol [In Process Citation[END_REF].

The cytochrome c pathway is distinct from that of AIF

The above described AIF could be a key regulator of such a cytochrome c-independent pathway inasmuch as these two mitochondrial components seem involved in distinct signaling route. Indeed, while AIF release occurs after the PT-associated mitochondrial depolarization, several reports indicates that cytochrome c release is dissociable from PT (Bossy- [START_REF] Bossy-Wetzel | Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization[END_REF][START_REF] Jurgensmeier | Bax directly induces release of cytochrome c from isolated mitochondria[END_REF]Kluck et al., 1997a;[START_REF] Li | Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade[END_REF][START_REF] Van Der Heiden | Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria[END_REF][START_REF] Yang | Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked[END_REF]. Furthermore, cytosolic cytochrome c requires additional cytosolic factors to promote apoptotic changes, via the activation of caspase-3, whereas AIF, once released from mitochondria, directly induces nuclear apoptosis without cytosol. Beyond their differences, these two "execution caspase" activating pathways illustrate the sophistication and the apparent molecular redundancy which characterize the mammalian cell death. They may correspond to alternative and independent links between death-triggering stimuli and the execution machinery or, in contrast, they may work together to induce complete PCD [START_REF] Golstein | Controlling Cell Death[END_REF].

Bcl-2 family proteins dock various proteins to the mitochondria

Even though, increasing reports provide evidence that Bcl-2 family members can modulate cell death process by directly controlling the availability of cytochrome c in the cytosol, it must underlined that pro-survival actors, as Bcl-2/ Bcl-xL, may also act downstream of cytochrome c to prevent caspase activation under certain circumstances [START_REF] Rosse | Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c[END_REF][START_REF] Zhivotovsky | Injected cytochrome c induces apoptosis[END_REF]. Moreover, effects of Bcl-2s cannot be reduced merely to models that envision Bcl-2s as regulators of killing caspase activation, inasmuch as Bcl-2 can also block caspase-independent cell deaths such as oxidant and hypoxia-induced necrosis, or Bax-induced yeast killing [START_REF] Jürgensmeier | Bax-and Bak-induced cell death in the fission yeast Schizosaccharomyces pombe[END_REF][START_REF] Manon | Release of cytochrome c and decrease of cytochrome c oxidase in Bax-expressing yeast cells, and prevention of these effects by coexpression of Bcl-xL[END_REF]. The ability of Bcl-2 to bind (at least in two hybrid or co-immunoprecipitation experiments) and to dock several cellular proteins that do not belong to the Bcl-2 related proteins family, can provide a clue to understand how the Bcl-2 family governs PCD.

First, Bcl-2 has been found to interact with Nip1, Nip2, and Nip3, the function of which is unknown [START_REF] Boyd | Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins[END_REF], the GTPase R-ras p23 [START_REF] Fernandez | Bcl-2 associates with the ras-related protein R-ras p23[END_REF], Raf-1 [START_REF] Ali | The study of cell death proteins in the outer mitochondrial membrane chemical cross-linking[END_REF][START_REF] Wang | Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase[END_REF], BAG-1 [START_REF] Takayama | Cloning and functional analysis of BAG-1: a novel Bcl-2binding protein with anti-cell death activity[END_REF], the cellular prion protein (PrP) [START_REF] Kurschner | The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid system[END_REF], the p53 binding-protein p53-BP2 [START_REF] Naumovski | The p53-binding protein 53BP2 also interacts with Bcl-2 and impedes cell cycle progression at G2/M[END_REF], the protein phosphatase calcineurin [START_REF] Shibasaki | Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2[END_REF] and the mitochondrial membrane protein carnitine palmitoyltransferase I [START_REF] Paumen | Direct interaction of the mitochondrial membrane protein carnitine palmitoyltransferase I with Bcl-2[END_REF]. At least some of these interactions could reflect the ability of Bcl-2 to relocalize cellular proteins to mitochondrial membranes.

Bcl-2 binds to BAG-1 [START_REF] Takayama | Cloning and functional analysis of BAG-1: a novel Bcl-2binding protein with anti-cell death activity[END_REF] that can also interact with Raf-1 (Wang et al., 1996b). Active Raf-1 fused with targeting sequences from an outer mitochondrial membrane protein protect cells from apoptosis and phosphorylate BAD, a proapoptotic Bcl-2 homologue (Wang et al., 1996a). Furthermore, plasma membrane-targeted Raf-1 did not protect from apoptosis and resulted in phosphorylation of ERK-1 and ERK-2 while Raf-1 improved Bcl-2-mediated resistance to apoptosis. Bcl-2 can therefore target

Raf-1 to mitochondrial membranes, allowing this kinase to phosphorylate BAD. However, the link between Raf-1 and the mitochondrial changes occurring during apoptosis are not yet known and bcl-2 does not always require c-raf-1 kinase activity and an associated mitogen-activated protein kinase signaling pathway for its survival function [START_REF] Olivier | Bcl-2 does not require Raf kinase activity for its death-protective function[END_REF].

Second, in accord with C. elegans genetics, biochemical evidences show that the pro-survival Bcl-2 family proteins may function by directly inhibiting the activation of killing caspases. It was initially shown that binding of CED-9 to CED-4 prevents CED-4 from inducing proteolytic processing and activation of CED-3 (Chinnaiyan et al., 1997b;Wu et al., 1997b). The CED-9 protein, like the mammalian Bcl-2 related proteins, is localized to intracellular membranes and the perinuclear region, whereas CED-4 was distributed in the cytosol. Expression of CED-9, but not a mutant lacking the carboxy-terminal hydrophobic domain, targeted CED-4 from the cytosol to intracellular membranes in mammalian cells (Wu et al., 1997b). A similar mechanism exists in mammalian cells as first suggested by the ability of Bcl-xL to interact with and inhibit the function of CED-4 (Chinnaiyan et al., 1997b). An ternary complex involving Apaf-1, caspase-9 and Bcl-xL, in which Bcl-xL inhibits

Apaf-1-mediated maturation of caspase-9, was found to be present in mammalian cells [START_REF] Hu | Bcl-x L interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation[END_REF][START_REF] Pan | Caspase-9, Bcl-x L , and Apaf-1 Form a Ternary Complex[END_REF] . The figure 2 illustrates that pro-apoptotic relatives like Bik, Bak and Bax can promote cell death by disrupting interaction between Bcl-xL and Apaf-1 (Chinnaiyan et al., 1997b;[START_REF] Pan | Caspase-9, Bcl-x L , and Apaf-1 Form a Ternary Complex[END_REF]. Such data explain how pro-survival actors, as Bcl-2/ Bcl-xL, may also act downstream of cytochrome c to prevent caspase activation under certain circumstances. For instance, overexpression of Bcl-2 and Bcl-xL inhibits apoptosis induced by direct injection of cytochrome c in cytosol (Li et al., 1997a;[START_REF] Zhivotovsky | Injected cytochrome c induces apoptosis[END_REF]. Similarly, Bcl-2 delays Bax-induced caspase activation and cell death even when cytochrome c is already in the cytosol [START_REF] Rosse | Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c[END_REF]. However, it must underlined that today there is no evidence concerning a physical interaction of Bcl-2 with apoptosome complex. Lastly, there is some evidence that binding of pro-survival proteins to the Apaf-1/caspase-9 complex alters its location in cells, dragging it from the cytosol to the intracellular membranes where Bcl-2s often reside (Chinnaiyan et al., 1997b;Wu et al., 1997b). In murine thymocytes, Bcl-2 is exclusively membrane-bound, whereas Bcl-xL is present in both soluble and membrane-bound forms and Bax is present predominantly in the cytosol.

Induction of apoptosis by dexamethasone or gamma-irradiation shifts the subcellular locations of Bax and Bcl-xL from soluble to membrane-bound forms. Inhibition of apoptosis with cycloheximide inhibits the movement of Bax and Bcl-xL from the cytosol into intracellular membranes [START_REF] Hsu | Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis[END_REF]. Since Bax and Bik can disrupt the association between CED-9 (or Bcl-xL) and CED-4 (Chinnaiyan et al., 1997b), it is tempting to speculate that Bcl-xL and possibly other members of the Bcl-2 protein family inhibit apoptosis by maintaining the procaspases/Apaf-1 complexes associated to mitochondrial membranes and that Bax and Bik by dissociating the complexes permit the activation of procaspases.

What is the mechanism involved in cytoplasmic release of mitochondrial apoptogenic factors?

The mechanism by which AIF and cytochrome c are released from mitochondria is largely unknown. Although apoptosis can occur in the absence of detectable cytochrome c release [START_REF] Chauhan | Cytochrome c-dependent and -independent induction of apoptosis in multiple myeloma cells[END_REF][START_REF] Tang | Apoptosis in the absence of cytochrome c accumulation in the cytosol [In Process Citation[END_REF], efflux of cytochrome c from mitochondria appears to be a critical coordinating step in the killing program towards which converge the multiple signaling pathways and beyond which are initiated the entire panel of apoptotic features, pro-caspase 3 expressing cells being then irreversibly committed to die (Li et al., 1997a). With this perspective, the possible mechanisms involved in activation of this central control may be envisaged from data concerning mediators of the death signal transduction cascades.

For instance, the release of cytochrome c might result from oxidative imbalance, an upstream event in the apoptotic transduction cascade (see below). This phenomena might lead to the alteration of some redox sensitive crucial regulatory elements of the outer mitochondrial membrane permeability, e.g. by a shift of the redox state of some sulfhydryl groups to a more inactivating oxidized state.

Another possibility comes from the ability of caspases to promote release intermembrane proteins, including cytochrome c and AIF, through the outer mitochondrial membrane. These observations suggested that mitochondria carry a caspase substrate that, when cleaved, promotes cytochrome c-release [START_REF] Mignotte | Mitochondria and apoptosis[END_REF]. Recent reports concerning Fas and TNF- receptor signaling could provide insight into how caspase induce cytochrome c efflux. Previously, it had been established that activation of caspases, predominantly the caspase-8, constitutes an early step in these apoptotic pathways [START_REF] Nagata | Apoptosis by Death Factor[END_REF], and that inhibition of these proteases prevents both the release of cytochrome c from mitochondria and the execution of the cell death program [START_REF] Schulze-Osthoff | Apoptosis signaling by death receptors[END_REF][START_REF] Van Der Heiden | Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria[END_REF]. Recently, it has been shown that caspase-8, activated by cell surface death receptors such as TNF and Fas, cleaves Bid, a death agonist of the Bcl-2 family, which in turn transduces the apoptotic signal from the cell surface to mitochondria [START_REF] Li | Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade[END_REF][START_REF] Luo | Bid, a Bcl-2 Interacting Protein, Mediates Cytochrome c release from Mitochondria in Response to Activation of Cell surface Death receptors[END_REF]. Thus, while fulllength Bid is localized in cytosol, the C-terminal part caspase-8-truncated BID translocates to mitochondria and then induces cytochrome c release and the downstream caspase-dependent apoptotic program.

These results point to a model where mitochondria might act as apoptotic amplifiers, fostering a positive feedback loop between cytochrome c-efflux and caspase activation. Any event that primes the loop will initiate the vicious "circle of death", leading to large-scale caspase activation and apoptotic cell death. However, this model does not prevail in all systems as, in numerous PCD, caspase inhibitors have no effect on the loss of cytochrome c [START_REF] Bossy-Wetzel | Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization[END_REF]Kluck et al., 1997a;Kluck et al., 1997b).

Alternatively, opening of PT pores, which is a common event of apoptosis, might be involved in AIF and cytochrome c outflow [START_REF] Skulachev | Cytochrome c in the apoptotic and antioxidant cascades[END_REF]. However,. PT pores, which are thought to connect the mitochondrial matrix to the cytosol, within the contact sites between inner and outer mitochondrial membranes [START_REF] Beutner | Complexes between kinases, mitochondrial porin and adenylate translocator in rat brain resemble the permeability transition pore[END_REF] are only permeable to small compounds (molecular mass <1500 Da) and therefore are probably not the structure directly responsible for the efflux of these intermembrane space apoptogenic proteins. Nevertheless, opening of the PT pore could be a first step of a cascade of events causing an increase in matrix volume and subsequently a mechanic disruption of the outer membrane. Recent results

show that this scenario is possible at least in vitro [START_REF] Petit | Disruption of the outer mitochondrial membrane as a result of large amplitude swelling: the impact of irreversible permeability transition[END_REF][START_REF] Scarlett | Release of apoptogenic proteins from the mitochondrial intermembrane space during the mitochondrial permeability transition[END_REF][START_REF] Van Der Heiden | Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria[END_REF].

Last, the pore-forming properties of Bax and other related proteins might suggest that they directly modulate the permeability of the outer mitochondrial membrane. Indeed, other studies have shown that Bax can induce cytochrome c release from mitochondria and caspase processing and activation [START_REF] Jurgensmeier | Bax directly induces release of cytochrome c from isolated mitochondria[END_REF]. These events are sensitive to Bcl-xL but caspase inhibitors have no effect on release of cytochrome c from mitochondria [START_REF] Gross | Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis[END_REF][START_REF] Xiang | BAX-induced cell death may not require interleukin 1-converting enzyme-like proteases[END_REF] although they prevent the subsequent activation of caspases in cytosolic extracts. Unlike Ca ++ , Bax did not induce PT and swelling of mitochondria in vitro in this system. These findings imply that Bax could uses an alternative mechanism for triggering release of cytochrome c from mitochondria. may be through to the action of specific pores in the outer membrane.

MITOCHONDRIAL ROS AND APOPTOSIS

SIGNALLING ROS as mediators of PCD

First evidence suggesting the involvement of mitochondria in cell death arose from the study of the TNF--induced cytotoxicity [START_REF] Lancaster | Inhibition of target cell mitochondrial electron transfer by tumor necrosis factor[END_REF][START_REF] Schulze-Osthoff | Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation[END_REF]. Indeed, an alteration of the mitochondrial function was associated with the early phases of the cell death and was defined as a crucial step of the process. The observed inhibition of the mitochondrial respiratory chain was assumed to result in the over production of Reactive Oxygen Species (ROS) which would act as mediators of the death signaling pathway [START_REF] Schulze-Osthoff | Depletion of the mitochondrial electron transport abrogates the cytotoxic and Gene-Inductive effects of TNF[END_REF].

ROS, such as superoxide anion, hydrogen, organic peroxides and radicals, are generated by all aerobic cells as byproducts of a number of metabolite reactions and in response to various stimuli [START_REF] Fridovich | The biology of oxygen radicals[END_REF].

Mitochondria are believed to be a major site of ROS production: superoxide radical is produced by a single electron transfer to molecular oxygen at the level of the respiratory chain, mainly at the ubiquinone site in complex III.

However, endoplasmic reticulum and nuclear membranes also contain e _ transport chains that can lose e _ and generate superoxide radical. Some fatty acid metabolites, such as those derived from arachidonic acid by the lipoxygenase pathway, are also ROS. However, ROS play a role in physiological systems : they were shown to be responsible for the inducible expression of genes associated with inflammatory and immune responses.

Current evidence indicates that different stimuli use ROS as signaling messengers to activate transcription factors, such as AP-1 and NF-B, and induce gene expression [START_REF] Pinkus | Role of Oxidants and Antioxidants in the Induction of AP-1, NF-kB, and Glutathione S-Transferase Gene Expression[END_REF].

The ability of oxidative stress, which is an excessive production of ROS, to provoke necrotic cell death as a result of massive cellular damages associated to lipid peroxidation and alterations of proteins and nucleic acids, is well documented for a long time [START_REF] Halliwell | Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease[END_REF]. The highly reactive hydroxyl radical ( . OH), by-product of superoxide anion or hydrogen peroxide, is assumed to be directly responsible for most of the oxidative damages leading to the non-physiological necrosis [START_REF] Halliwell | Role of free radicals and catalytic metal ions in human disease: an overview[END_REF]. To prevent oxidative damage, mammalian cells have developed a complex antioxidant defense system that includes nonenzymatic antioxidants (e.g. glutathione, thioredoxine) as well as enzymatic activities (e.g. catalase, superoxide dismutase (SOD)) [START_REF] Sies | Oxidative stress: from basic research to clinical application[END_REF]. In this point of view, aerobic cells appear as being under a continual ''oxidative siege", their survival depending on a balance between ROS and antioxidants. On the other hand, the possible implication of ROS as signaling molecules in more physiological deaths such as PCD is an emerging concept. Thus, since the initial observation outlining the contribution of ROS to the TNF--induced cytotoxicity, there is mounting evidence that these compounds may be central in the cell death transduction pathways. Indeed, several observations suggest that ROS might mediate PCD:

1) the addition of ROS or the depletion of endogenous antioxidants can promote cell death [START_REF] Guénal | Bcl-2 and Hsp27 act at different levels to suppress programmed cell death[END_REF][START_REF] Kane | Bcl-2 inhibition of neural deathdecreased generation of reactive oxygen species[END_REF][START_REF] Lennon | Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli[END_REF][START_REF] Ratan | Oxidative stress induces apoptosis in embryonic cortical neurons[END_REF][START_REF] Sato | Thiol-Mediated Redox Regulation of Apoptosis. Possible roles of cellular thiols other than glutathione in T cell apoptosis[END_REF], 2) PCD can sometimes be delayed or inhibited by antioxidants [START_REF] Greenlund | Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death[END_REF][START_REF] Mayer | N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro[END_REF][START_REF] Mehlen | Small stress proteins as novel regulators of apoptosis[END_REF][START_REF] Sandstrom | Autocrine production of extracellular catalase prevents apoptosis of the human CEM T-cell line in serum-free medium[END_REF][START_REF] Wong | Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor[END_REF] and 3) increases in intracellular ROS are sometimes associated with PCD [START_REF] Martin | Ultraviolet B irradiation of human leukaemia HL-60 cells in vitro induces apoptosis[END_REF][START_REF] Quillet-Mary | Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis[END_REF][START_REF] Uckun | Ionizing radiation stimulates unidentified Tyrosine-Specific protein kinases in human Lymphocyte-B precursors, triggering apoptosis and clonogenic cell death[END_REF]. Moreover, it was shown that Bcl-2 may act in an antioxidant pathway to block a putative ROSmediated step in the cascade of events required for PCD (see below). So, in addition to their role in TNF--induced killing, the contribution of ROS to the activation of the execution machinery was extended to PCD triggered by a wide range of influences including UV light, ionizing irradiation, anthracyclines, ceramides, glucocorticoids or survival-factor withdrawal (see [106]. Moreover some data raise the possibility that ROS are also required for the execution of the death program [START_REF] Kroemer | The biochemistry of programmed cell death[END_REF]. However, they must be cautiously considered inasmuch as, in the majority of these systems, it is difficult to ascertain that the observed ROS accumulation corresponds to a causal effect and is not a side effect of the other changes accompanying the killing process [START_REF] Cai | Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss[END_REF]. Moreover, in these cases, ROS increase most often arises during the later stage of the death program, i.e. during the destruction phase when the cell is broken down, and may be associated with a necrotic type terminal degradation of the cell. Exogenous sources of ROS such as hydrogen peroxide can induce PCD or necrosis depending upon the dose added [START_REF] Guénal | Bcl-2 and Hsp27 act at different levels to suppress programmed cell death[END_REF]. So a burst in ROS, in response to a dramatic perturbation of the physiology of the dying cell, could convert the late PCD steps into necrotic death. Therefore, it appears that at any moment the level of intracellular ROS can determine the fate of the cell: low levels of ROS can induce PCD while accumulation of high levels promotes necrosis or can lead PCD-committed cells toward necrotic-like destruction.

PCD-mediating ROS are produced by mitochondria

The nature of the ROS involved in PCD is a conflicting question that will allow us to return to the central subject of this review, i.e. the role of mitochondria in PCD. Indeed, two opposite models have emerged concerning the source of signaling ROS, in relation with the variety of metabolic reactions and intracellular sites which can generate ROS (see above) [START_REF] Jacobson | Reactive oxygen species and programmed cell death[END_REF].

While most investigators believe that oxidants are produced by electron chain transport, some data seem to moderate this point of view. Fatty acid metabolites, such as those produced from arachidonic acid by the lipoxygenase pathway, may be better mediators of PCD [START_REF] O'donnell | Involvement of oxidants and oxidant-generating enzyme(s) in tumour-necrosis-factor-alpha-mediated apoptosis: role for lipoxygenase pathway but not mitochondrial respiratory chain[END_REF]. On the one hand, it is argued that these molecules harbor a more specific reactivity than superoxide anion and its by-products, this biological specificity being assumed necessary for a signaling role in PCD transduction pathways. On the other hand, it was shown that exogenous fatty acid metabolites can promote PCD and that, in some cases, their increased production was associated with cell death. It must be underlined that such a situation is limited to systems where the death signal result is mediated by surface receptors. Nevertheless, these considerations do not refute the compelling evidence of the involvement of electron transport chain-produced ROS in cell death signaling. It appears more reasonable to consider that, depending upon the cell death stimulus and the cell model, these two types of ROS can mediate PCD or even both contribute to the activation of the execution machinery as suggested by studies of TNF--induced PCD.

Where are localized the electron transport chains that produce cell death signaling ROS such as hydrogen peroxide? The question must address distinct intracellular compartments as reticulum endoplasmic, nuclear layer and especially mitochondria. The more convincing responses have arisen from indirect studies measuring the consequences of an alteration of the electron transport chain on the PCD process. In this way, it was established that both ROS accumulation and PCD process require the presence of a functional mitochondrial respiratory chain in most ROS-dependent cell death systems [START_REF] Higuchi | Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function[END_REF][START_REF] Quillet-Mary | Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis[END_REF][START_REF] Schulze-Osthoff | Depletion of the mitochondrial electron transport abrogates the cytotoxic and Gene-Inductive effects of TNF[END_REF][START_REF] Sidoti-De Fraisse | TNF- activates at least two apoptotic signaling cascades[END_REF]. Indeed, it was shown that an upstream inhibition, with chemical compounds acting on complex I (Quillet- [START_REF] Quillet-Mary | Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis[END_REF][START_REF] Schulze-Osthoff | Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation[END_REF], or an elimination of the electron transfer chain [START_REF] Higuchi | Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function[END_REF][START_REF] Schulze-Osthoff | Depletion of the mitochondrial electron transport abrogates the cytotoxic and Gene-Inductive effects of TNF[END_REF][START_REF] Sidoti-De Fraisse | TNF- activates at least two apoptotic signaling cascades[END_REF], by depletion of the mtDNA, prevent ROS accumulation and consequently protect cells against PCD. Another indirect argument is provided by the scavenger role of mitochondrial glutathione in the regulation of ROSmediated PCD (Goossens et al., 1995). The ubiquinone site in complex III appears as the major site of mitochondrial ROS production as this site catalyzes the conversion of molecular oxygen to superoxide anion which can lead to the formation of other potent ROS such as hydrogen peroxide and hydrogen radicals. Such a model is supported by the observed potentiation of cell death processes in ROS-dependent PCD when electron flow was inhibited distal to the ubiquinone pool.

Mechanisms of ROS signaling

The involvement of mitochondrial ROS in some cell death transduction pathways next leads to the fundamental questions concerning, on the one hand, the causal event of the increased ROS generation and, on the other hand, the molecular mechanisms underlying the ROS signaling. Two viewpoints must first be considered to address the question of the origin of ROS accumulation, which can indeed result from an increased production or from a reduced scavenging by the cellular detoxifying systems. Much of the available data converge to the hypothesis that ROS increases are the consequence of an impairment of the mitochondrial respiratory chain [START_REF] Cai | Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss[END_REF][START_REF] Degli Esposti | Mitochondria and cells produce reactive oxygen species in virtual anaerobiosis: relevance to ceramide-induced apoptosis[END_REF][START_REF] France-Lanord | Mitochondrial free radical signal in ceramide-dependent apoptosis: a putative mechanism for neuronal death in Parkinson's disease[END_REF][START_REF] Gudz | Direct inhibition of mitochondrial respiratory cahin complex III by cell-permeable ceramide[END_REF][START_REF] Quillet-Mary | Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis[END_REF][START_REF] Schulze-Osthoff | Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation[END_REF]. In agreement with the above considerations, the observed alterations are distal to the ubiquinone site of the complex III, but the origin of these electron flow disturbances are not clear. The only strong evidence comes from the study of ceramide-induced PCD, in which an increased H2O2 production was linked to mitochondrial Ca 2+ homeostasis perturbation as inhibition of the mitochondrial Ca 2+ uptake was shown to abolish both ROS accumulation and cell death. However, the recently observed shift of cytochrome c from mitochondria to cytosol in the early phases of many PCD (see above) could provide a clue to resolve this question (Kluck et al., 1997a;[START_REF] Liu | Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c[END_REF][START_REF] Yang | Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked[END_REF]. Indeed, the release of cytochrome c must lead to a breakdown of the mitochondrial electron flow downstream of the ubiquinone site which in turn would result in an increased generation of ROS. Such a model is supported by the described correlation between loss of cytochrome c activity and respiratory failure in a

Fas-induced PCD model [START_REF] Krippner | Loss of Function of Cytochrome c in Jurkat Cells Undergoing Fas-mediated Apoptosis[END_REF] and by the study of mitochondria isolated from apoptotic cells which shows a superoxide production due to a switch from the normal 4-electron reduction of O2 to a 1-electron reduction when cytochrome c is released from mitochondria. [START_REF] Cai | Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss[END_REF].

Beside the question of the process of mitochondrial ROS accumulation, arises the problematic concerning the targets of these compounds or more precisely: how can they mediate PCD? Two models can be proposed to approach this conflicting and not well documented subject. The first model assumes that ROS themselves are signaling molecules which activate some crucial components of the PCD machinery. Conversely, the alternative proposition suggests that ROS can act indirectly by modifying the cellular redox potential, which would regulate some key regulatory proteins involved in PCD. Several lines of evidence agree with an explanation based on indirectly mediated action. First, unlike fatty acid metabolites which harbor specific reactivity and are known to mediate particular signals from surface receptors, mitochondrial ROS are characterized by a lack of biological specificity or even an extreme reactivity, as for the hydroxyl radical: these are all features contrary to the requirements of a specific signaling role [START_REF] Jacobson | Reactive oxygen species and programmed cell death[END_REF]. In this way, a direct influence of ROS on PCD process would be correlated to a general damaging effect on cellular structures resulting in necrotic cell death, or perhaps to a more limited action on mitochondria, their site of production, which in turn could activate some mitochondria-dependent downstream cascades leading to PCD. Secondly, despite the compelling evidence of the role of mitochondrial ROS in PCD signaling pathways, it has been assumed that they do not represent a general mediator of cell death, as suggested by the ability of some PCD to occur in very low oxygen environments [START_REF] Jacobson | Programmed cell death and Bcl-2 protection in very low oxygen[END_REF][START_REF] Shimizu | Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-X L[END_REF]. However, ROS might be produced in such conditions [START_REF] Degli Esposti | Mitochondria and cells produce reactive oxygen species in virtual anaerobiosis: relevance to ceramide-induced apoptosis[END_REF].

Another alternative explanation would be to consider that the major effect of an increased ROS production is the subsequent imbalance of intracellular redox status, i.e. an enhancement of the cellular oxidative tonus, and that in fact the oxidative stress is the central common effector of PCD. Hence, ROS accumulation would only be one way which leads in some PCD to an oxidative status. Anti-Fas/APO-1 antibody or IL-3 withdrawal-induced PCD represent good illustrations of this model [START_REF] Bojes | Bcl-x L overexpression attenuates glutathione depletion in FL5.12 cells following interleukin-3 withdrawal[END_REF][START_REF] Van Den Dobbelsteen | Rapid and Specific Efflux of Reduced Glutathione during Apoptosis Induced by Anti-Fas/APO-1 Antibody[END_REF]. Indeed, no ROS accumulation can be measured in these two systems and anareobic cultured cells deprived of IL-3 still undergo PCD [START_REF] Schulze-Osthoff | Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death[END_REF][START_REF] Shimizu | Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-X L[END_REF]. However, an oxidative stress can be shown in these models as a depletion of glutathione (GSH), a non-enzymatic cellular antioxidant, as a result of a rapid and specific efflux of glutathione, an event that takes place at the very beginning of the apoptotic process [START_REF] Bojes | Bcl-x L overexpression attenuates glutathione depletion in FL5.12 cells following interleukin-3 withdrawal[END_REF][START_REF] Van Den Dobbelsteen | Rapid and Specific Efflux of Reduced Glutathione during Apoptosis Induced by Anti-Fas/APO-1 Antibody[END_REF].

Moreover, it has been shown that Bcl-2 can protect cells from PCD by shifting the cellular redox potential to a more reduced state (see below). However, the observation that oxidation of thiols other than glutathione can mediate induction of PCD suggest that the intracellular thiol redox status would be the real key factor of the cell death signaling pathways [START_REF] Kane | Bcl-2 inhibition of neural deathdecreased generation of reactive oxygen species[END_REF][START_REF] Marchetti | Redox regulation of apoptosis: impact of thiol oxidation status on mitochondrial function[END_REF][START_REF] Mirkovic | Resistance to radiation-induced apoptosis in Bcl-2expressing cells is reversed by depleting cellular thiols[END_REF][START_REF] Sato | Thiol-Mediated Redox Regulation of Apoptosis. Possible roles of cellular thiols other than glutathione in T cell apoptosis[END_REF]. In this model, the redox state of glutathione or other cellular antioxidants such as thioredoxine, would be in equilibrium with that of thiols resident in some redox sensitive crucial components of the execution machinery [START_REF] Kroemer | The proto-oncogene Bcl-2 and its role in regulating apoptosis[END_REF]. Where does ROS fit this thiol hypothesis? In this putative model, an increased production of mitochondrial ROS would result, either by a direct modification of the thiols or indirectly via a depletion of the intracellular antioxidant pool, in a shift of the redox state of the sensor SH groups to a more oxidized state. The nature of the ROS and the level of the intracellular antioxidant defenses would determine in which way regulatory components are activated to commit cells to PCD. In an hypothetical model (figure 3), mitochondrial ROS modify the membrane permeability leading to the release of pro-apoptotic factors and/or activate directly executing caspases.

Several lines of evidence support the idea that Bcl-2 acts in an antioxidant pathway to suppress apoptosis. Yeast mutants lacking superoxide dismutase were partially rescued by expression of Bcl-2 [START_REF] Kane | Bcl-2 inhibition of neural deathdecreased generation of reactive oxygen species[END_REF][START_REF] Longo | Human Bcl-2 reverses survival defects in yeast lacking superoxide dismutase and delays death of wild-type yeast[END_REF]. Following an apoptotic signal, overexpression of Bcl-2 suppressed lipid peroxidation completely [START_REF] Hockenbery | Bcl-2 functions in an antioxidant pathway to prevent apoptosis[END_REF]. Bcl-2 deficient mice turn gray with the second hair follicle cycle, implicating possibly a defect in redox-regulated melanin synthesis [START_REF] Veis | Bcl-2-Deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair[END_REF]. Bcl-2 can protect neural cells from delayed death resulting from chemical hypoxia and reenergization, and may do so by an antioxidant mechanism [START_REF] Myers | Bcl-2 protects neural cells from cyanide/aglycemiainduced lipid oxidation, mitochondrial injury, and loss of viability[END_REF] (reviewed in [START_REF] Korsmeyer | Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family[END_REF]).

The way by which Bcl-2 protects from ROS remains unclear. In some systems, Bcl-2 appears to influence the generation of oxygen free radicals [START_REF] Kane | Bcl-2 inhibition of neural deathdecreased generation of reactive oxygen species[END_REF] while in other cases it does not affect ROS production but does prevent oxidative damage to cellular constituents [START_REF] Hockenbery | Bcl-2 functions in an antioxidant pathway to prevent apoptosis[END_REF][START_REF] Tyurina | Direct evidence for antioxidant effect of Bcl-2 in PC12 rat pheochromocytoma cells[END_REF]. Alternatively, since superoxide is produced by mitochondria from apoptotic cells due to a switch from the normal 4-electron reduction of O2 to a 1-electron reduction, the block of cytochrome c release could provides a mechanism for the apparent antioxidant function of Bcl-2 [START_REF] Cai | Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss[END_REF].

Several authors have studied the effect of Bcl-2 family proteins on cellular redox potential. Activities of antioxidant enzymes and levels of glutathione and pyridine nucleotides have been measured in pheochromocytoma PC12 and the hypothalamic GnRH cell line GT1-7 cells transfected with bcl-2 [START_REF] Ellerby | Shift of the cellular oxidation-reduction potential in neural cells expressing Bcl-2[END_REF]. Both cell lines overexpressing bcl-2 had elevated total glutathione levels when compared with control transfectants. The ratios of oxidized glutathione to total glutathione in PC12 and GT1-7 cells overexpressing bcl-2 were significantly reduced. In addition, the NAD+/NADH ratio of bcl-2-expressing PC12 and GT1-7 cells was two-to threefold less than that of control cell lines while they had approximately the same level of catalase, superoxide dismutase, glutathione peroxidase and glutathione reductase activities as control cells. These results indicate that the overexpression of bcl-2 shifts the cellular redox potential to a more reduced state, without consistently affecting the major cellular antioxidant enzymes.

Furthermore, depleting cellular thiols reversed the resistance to radiation in Bcl-2 expressing lymphoma cell lines [START_REF] Mirkovic | Resistance to radiation-induced apoptosis in Bcl-2expressing cells is reversed by depleting cellular thiols[END_REF].

The ability of bax and bcl-xL to affect GSH was assessed in interleukin (IL)-3-dependent murine prolymphocytic FL5.12 cells [START_REF] Bojes | Bcl-x L overexpression attenuates glutathione depletion in FL5.12 cells following interleukin-3 withdrawal[END_REF].

Overall levels of GSH increased in bcl-xL transfectants while, in cells overexpressing bax, GSH was reduced by approximately 36%. There were no consistent differences between these cell lines in the activities of superoxide dismutase, catalase, glutathione peroxidase or glutathione reductase. Assuming that all mammalian cells constitutively express all the protein components required to execute the death program [START_REF] Jacobson | Programmed Cell Death and Bcl-2 Protection in the Absence of a Nucleus[END_REF], these results suggest that Bax (or an other similar pro-apoptotic member of the Bcl-2 family) are ubiquitously expressed and that survival requires their continuous inhibition. Taking into account the mitochondrial membrane localization of these proteins and their pore forming properties, it can be proposed that this kind of regulation operates at the mitochondrial level to control membrane permeability and efflux of AIF and cytochrome c.

The mechanism allowing for the release of AIF and cytochrome c needs further investigations. Opening of the PT pore could be just a first step of a cascade of events causing an increase in the permeability of the outer mitochondrial membrane. At present, it remains elusive whether this permeability increase is due to the action of specific pores in the outer membrane and/or to its mechanic disruption secondary to an increase in matrix volume.

Another exciting question to resolve is the occurrence of an apoptosislike phenotype associated with a specific mutation in S. cerevisiae [START_REF] Madeo | A yeast mutant showing diagnostic markers of early and late apoptosis[END_REF]. This yeast species seems do not contain caspases or Bcl-2s gene and its cytochrome c has been shown to be ineffective to induce nuclear apoptosis in acellular assay (Kluck et al., 1997b). These data suggest the existence of yet unknown PCD pathways in which the place and the role of mitochondria remain to be determined.

  The actors of the execution stage of the apoptotic cascade Bcl-2 family proteins act at least in part at the mitochondrial level PERMEABILITY TRANSITION MARKS A POINT OF NO-RETURN OF CELLS CONDEMNED TO DIE A decrease in mitochondrial membrane potential precedes DNA fragmentation during apoptosis Mitochondrial permeability transition provokes a m decrease Direct interventions on the mitochondrial permeability transition modulate apoptosis MITOCHONDRIA OF CELLS UNDERGOING APOPTOSIS RELEASE PRO-APOPTOTIC FACTORS Mitochondria undergoing permeability transition liberate AIF factor.

Following

  IL-3 withdrawal-induced apoptosis, control cells and bax transfectants exhibit a rapid loss of intracellular GSH that seemed to occur due to a translocation out of the cell. Cells overexpressing bcl-xL did not lose significant amounts of GSH upon withdrawal of IL-3, and no apoptosis was evident. These results suggest a possible role for GSH in the mechanism by which Bcl-xL prevents cell death. Thus, both Bcl-2 and Bcl-xL can protect cells from apoptosis by shifting the cellular redox potential to a more reduced state. Assuming that mitochondrial thiols constitute a critical sensor of the cellular redox potential during apoptosis[START_REF] Marchetti | Redox regulation of apoptosis: impact of thiol oxidation status on mitochondrial function[END_REF], these effects could be at the mitochondrial level.CONCLUSIONSIn conclusion, mitochondria are involved in the decision of cells to survive or not at several levels. At a first level, mitochondria can contribute to apoptosis signaling, as shown in TNF--or ceramide-induced cell death during which increased mitochondrial ROS production appears as an early event of the induction phase. At a second level, mitochondria are involved in the control of the activation of the cell death machinery by docking at their surface, via Bcl-2 family proteins, execution caspases or by sequestering, in the intermembrane space, caspase activators as AIF or cytochrome c. This recent accumulation of data has also generated a number of new questions. Future works must address the connection between survival signals and mitochondrial functions. The study of Bad regulation, a proapoptotic Bcl-2 member which is supposed to counteract Bcl-2 has provided an example of how survival factors counteract PCD. Indeed, Bad is inactivated by phosphorylation by Akt[START_REF] Datta | Akt phosphorylation of BAD couples survival signals to the cellintrinsic death machinery[END_REF][START_REF] Del Peso | Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt[END_REF] and Raf-1(Wang et al., 1996a), two kinases involved in survival signals transduction. It has been suggested that, in the absence of phosphorylation, Bad induces cell death possibly via the formation of heterodimers with Bcl-xL (or Bcl-2 depending of the cell type) and the concomitant generation of Bax homodimers.

Figure 1 .

 1 Figure 1. Simplified model of events occurring during apoptosis

Figure 2 .

 2 Figure 2. Bcl-2 family proteins regulates the intracellular localization and

Figure 3 .

 3 Figure 3. Mitochondrial ROS contribute to apoptosis signaling

C. elegans Mammals

CED-3

Activation caspases: caspase-1 (ICE), -4 (ICH-2), -6 (Mch2), -8

(MACH/FLICE)...

Execution caspases: caspase-2 (ICH-1), -3 (CPP32), -4 (ICH-2), -7

(ICE-LAP3)...

CED-4

CED-9 (Li et al., 1997b)

Pro-apoptotic: Bax, Bak, Bcl-xS, Bad, Bik, Hrk… Table I: Programmed cell death in nematodes and mammals is controlled by homologous proteins. Mammalian caspases act either during the activation or the execution phase of PCD [START_REF] Nicholson | Caspases: killer proteases[END_REF]. Recently, a CED-4 homologue has been identified in human cells [START_REF] Hofmann | The CARD domain: a new apoptotic signalling motif[END_REF][START_REF] Zou | Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3[END_REF]. In mammals some members of the Bcl-2 related proteins are death antagonists while other are death agonists. For a recent review on the structure-function relations of Bcl-2 related proteins see [START_REF] Kroemer | The proto-oncogene Bcl-2 and its role in regulating apoptosis[END_REF].